⌘K

Login Start Free

Home/Filings/4/0001062993-25-002703

4//SEC Filing

Doyle John Brendan 4

Accession 0001062993-25-002703

CIK 0001455365other

View on SEC.gov Company Profile

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 4:28 PM ET

Size

4.8 KB

Accession

0001062993-25-002703

Insider Transaction Report

Form 4

Period: 2025-02-15

COGNITION THERAPEUTICS INCCGTX

Doyle John Brendan

Chief Financial Officer

Transactions

Tax Payment
Common Stock
2025-02-15$0.59/sh−1,723$1,017→ 414,402 total

Footnotes (1)

[F1]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

COGNITION THERAPEUTICS INC

CIK 0001455365

Entity typeother

Related Parties

1

filerCIK 0001840738

Filing Metadata

Form type: 4
Filed: Feb 17, 7:00 PM ET
Accepted: Feb 18, 4:28 PM ET
Size: 4.8 KB

View on SEC.gov